Welcome to LookChem.com Sign In|Join Free

CAS

  • or

32634-68-7

Post Buying Request

32634-68-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

32634-68-7 Usage

Chemical Properties

white to light yellow crystal powde

Uses

Different sources of media describe the Uses of 32634-68-7 differently. You can refer to the following data:
1. blood volume expander
2. Inhibitor of enzyme. Rivastigmine USP Related Compound A.

Flammability and Explosibility

Notclassified

Check Digit Verification of cas no

The CAS Registry Mumber 32634-68-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,2,6,3 and 4 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 32634-68:
(7*3)+(6*2)+(5*6)+(4*3)+(3*4)+(2*6)+(1*8)=107
107 % 10 = 7
So 32634-68-7 is a valid CAS Registry Number.
InChI:InChI=1/C18H18O6/c1-11-3-7-13(8-4-11)23-15(17(19)20)16(18(21)22)24-14-9-5-12(2)6-10-14/h3-10,15-16H,1-2H3,(H,19,20)(H,21,22)

32634-68-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (D1417)  (+)-Di-p-toluoyl-D-tartaric Acid  >98.0%(HPLC)(T)

  • 32634-68-7

  • 25g

  • 610.00CNY

  • Detail
  • TCI America

  • (D1417)  (+)-Di-p-toluoyl-D-tartaric Acid  >98.0%(HPLC)(T)

  • 32634-68-7

  • 250g

  • 2,590.00CNY

  • Detail
  • Alfa Aesar

  • (L13223)  Di-p-toluoyl-D-tartaric acid, 98%   

  • 32634-68-7

  • 5g

  • 323.0CNY

  • Detail
  • Alfa Aesar

  • (L13223)  Di-p-toluoyl-D-tartaric acid, 98%   

  • 32634-68-7

  • 25g

  • 1038.0CNY

  • Detail
  • Alfa Aesar

  • (L13223)  Di-p-toluoyl-D-tartaric acid, 98%   

  • 32634-68-7

  • 100g

  • 2963.0CNY

  • Detail
  • Aldrich

  • (302813)    made from synthetic tartaric acid, 97%

  • 32634-68-7

  • 302813-25G

  • 504.27CNY

  • Detail
  • Aldrich

  • (302813)    made from synthetic tartaric acid, 97%

  • 32634-68-7

  • 302813-100G

  • 1,295.19CNY

  • Detail

32634-68-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,3-Di-O-para-toluoyl-D-tartaric acid

1.2 Other means of identification

Product number -
Other names D-PTTA

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:32634-68-7 SDS

32634-68-7Synthetic route

rac-O,O'-di-p-toluoyltartaric acid
32634-66-5, 32634-68-7, 100168-11-4, 104528-81-6

rac-O,O'-di-p-toluoyltartaric acid

(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

Conditions
ConditionsYield
ueber das Cinchonin-Salz;
di-O-p-toluoyl-Dg-tartaric acid-anhydride

di-O-p-toluoyl-Dg-tartaric acid-anhydride

(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

Conditions
ConditionsYield
With water; acetone
(R)-2-cyclopropylaminocyclohexanol di-p-toluoyl-D-tartrate
339546-21-3

(R)-2-cyclopropylaminocyclohexanol di-p-toluoyl-D-tartrate

A

(R)-2-cyclopropylaminocyclohexanol
339546-20-2

(R)-2-cyclopropylaminocyclohexanol

B

(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

Conditions
ConditionsYield
With sodium hydroxide In water at 20 - 30℃; for 1h; Product distribution / selectivity;A n/a
B n/a
(+)-di-O,O'-toluoyl-D-tartaric acid mono-NH4 salt

(+)-di-O,O'-toluoyl-D-tartaric acid mono-NH4 salt

(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

Conditions
ConditionsYield
With Amberlite 1R In isopropyl alcohol Product distribution / selectivity;
With hydrogenchloride In dichloromethane; water pH=< 0.5; Product distribution / selectivity;
(3S,4S)-2,5-dioxotetrahydrofuran-3,4-diyl bis(4-methylbenzoate)
72842-25-2

(3S,4S)-2,5-dioxotetrahydrofuran-3,4-diyl bis(4-methylbenzoate)

(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

Conditions
ConditionsYield
With water In toluene for 5h; Reflux; Large scale;374.4g
rac-O,O'-di-p-toluoyltartaric acid
32634-66-5, 32634-68-7, 100168-11-4, 104528-81-6

rac-O,O'-di-p-toluoyltartaric acid

A

Di-p-toluoyl-L-tartaric acid
32634-66-5

Di-p-toluoyl-L-tartaric acid

B

(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

Conditions
ConditionsYield
With C22H24N2(2+)*2CF3O3S(1-) In aq. acetate buffer at 20℃; pH=8.1; Resolution of racemate;
(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

(R,S)-3-iso-butyl-4-aminobutyric acid
128013-69-4, 130912-52-6, 148553-50-8, 148553-51-9

(R,S)-3-iso-butyl-4-aminobutyric acid

A

(S)-pregabalin O,O'-di-p-toluoyl-(D)-tartrate

(S)-pregabalin O,O'-di-p-toluoyl-(D)-tartrate

B

(R)-pregabalin O,O'-di-p-toluoyl-(D)-tartrate

(R)-pregabalin O,O'-di-p-toluoyl-(D)-tartrate

Conditions
ConditionsYield
In water; butan-1-ol at 20 - 25℃; Resolution of racemate;A 98%
B n/a
(R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine
753015-44-0

(R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine

(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

(R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine mono-di-p-toluoyl-D-tartarate
1228391-41-0

(R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine mono-di-p-toluoyl-D-tartarate

Conditions
ConditionsYield
In ethanol Reflux;96.1%
In ethanol Reflux;96.1%
rac-trans-2-methylamino-cyclohexanol
20431-81-6

rac-trans-2-methylamino-cyclohexanol

(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

A

2C7H15NO*C20H18O8

2C7H15NO*C20H18O8

B

trans-2-(methylamino)cyclohexanol
21651-84-3

trans-2-(methylamino)cyclohexanol

Conditions
ConditionsYield
In ethanol at 45 - 60℃; for 1h;A 95%
B n/a
7-trifluoromethyl-2,3,4,5-tetrahydro-1,5-methylene-1H-3-benzazepine

7-trifluoromethyl-2,3,4,5-tetrahydro-1,5-methylene-1H-3-benzazepine

(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

(1S,8R)-(+)-4-trifluoromethyl-10-azatricyclo[6.3.1.0(2,7)]dodeca-2(7),3,5-triene di-p-toluoyl-D-(-)-tartaric acid salt
873788-21-7

(1S,8R)-(+)-4-trifluoromethyl-10-azatricyclo[6.3.1.0(2,7)]dodeca-2(7),3,5-triene di-p-toluoyl-D-(-)-tartaric acid salt

Conditions
ConditionsYield
In acetonitrile at 82℃; for 1 - 24h; Product distribution / selectivity;94%
(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

(4aS,8aS)-rel-3-methoxy-11-methyl-4a,5,9,10,11,12-hexahydro-6H-benzo[2,3]benzofuro[4,3-cd]azepin-6-one
510-77-0, 1668-86-6, 7318-55-0

(4aS,8aS)-rel-3-methoxy-11-methyl-4a,5,9,10,11,12-hexahydro-6H-benzo[2,3]benzofuro[4,3-cd]azepin-6-one

[(-)-narwedine][di-p-toluoyl-D-tartrate]

[(-)-narwedine][di-p-toluoyl-D-tartrate]

Conditions
ConditionsYield
In ethanol at 40℃; Heating / reflux;90%
(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

2-(tert-butylamino)-1-(2,2-dimethyl-4H-benzo[d][1,3]dioxan-6-yl)ethanol
54208-72-9

2-(tert-butylamino)-1-(2,2-dimethyl-4H-benzo[d][1,3]dioxan-6-yl)ethanol

2C16H25NO3*C20H18O8

2C16H25NO3*C20H18O8

Conditions
ConditionsYield
In methanol for 0.166667h; Heating / reflux;90%
In methanol for 0.25h; Heating / reflux;73%
2-(1-aminoethyl)-N-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide
1095823-56-5

2-(1-aminoethyl)-N-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide

(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

A

C12H10ClF3N4OS
1095825-44-7

C12H10ClF3N4OS

B

C12H10ClF3N4OS*C20H18O8
1095823-60-1

C12H10ClF3N4OS*C20H18O8

Conditions
ConditionsYield
In water; isopropyl alcohol at 45 - 53℃; for 21h; Purification / work up; Resolution of racemate;A n/a
B 88%
(8-hydroxy-4,5-dibromo-1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-yl)acetonitrile

(8-hydroxy-4,5-dibromo-1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-yl)acetonitrile

(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

2-(1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethylaminedi-p-toluoyl-L-(-)-tartrate

2-(1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethylaminedi-p-toluoyl-L-(-)-tartrate

Conditions
ConditionsYield
Stage #1: (8-hydroxy-4,5-dibromo-1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-yl)acetonitrile With ammonia; hydrogen In ethanol at 55℃; under 18751.9 Torr; for 15h;
Stage #2: (2S,3S)-di-4-toluoyltartaric acid at 20℃; for 0.75h; Temperature; Pressure; Solvent;
87.8%
(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

lofexidine hydrochloride
21498-08-8

lofexidine hydrochloride

A

(+/-)-lofexidine di-p-toluoyl-D-tartarate

(+/-)-lofexidine di-p-toluoyl-D-tartarate

B

(+/+)-lofexidine di-p-toluoyl-D-tartarate

(+/+)-lofexidine di-p-toluoyl-D-tartarate

Conditions
ConditionsYield
In ethanolA 87%
B n/a
(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

(S)-1-(2-piperidino-phenyl)-3-methyl-1-butylamine
108157-52-4

(S)-1-(2-piperidino-phenyl)-3-methyl-1-butylamine

(S)-3-methyl-1-(2-piperidino-phenyl)-1-butylamine di-p-toluoyl-D-tartaric acid salt
1098066-89-7

(S)-3-methyl-1-(2-piperidino-phenyl)-1-butylamine di-p-toluoyl-D-tartaric acid salt

Conditions
ConditionsYield
With toluene-4-sulfonic acid In methanol; water at 25 - 60℃; Product distribution / selectivity;85.7%
(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

(4aS,8aS)-rel-3-methoxy-11-methyl-4a,5,9,10,11,12-hexahydro-6H-benzo[2,3]benzofuro[4,3-cd]azepin-6-one
510-77-0, 1668-86-6, 7318-55-0

(4aS,8aS)-rel-3-methoxy-11-methyl-4a,5,9,10,11,12-hexahydro-6H-benzo[2,3]benzofuro[4,3-cd]azepin-6-one

[(-)-narwedine]2[di-p-toluoyl-D-tartrate]

[(-)-narwedine]2[di-p-toluoyl-D-tartrate]

Conditions
ConditionsYield
In ethanol at 20 - 40℃; for 19h; Heating / reflux;83%
In ethanol at 40℃; Heating / reflux;79%
5-azaspiro[2.4]heptane-6-carboxylic acid

5-azaspiro[2.4]heptane-6-carboxylic acid

(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

(S)-5-azaspiro[2.4]heptane-6-carboxylic acid D-di-p-methylbenzoyltartrate

(S)-5-azaspiro[2.4]heptane-6-carboxylic acid D-di-p-methylbenzoyltartrate

Conditions
ConditionsYield
Stage #1: 5-azaspiro[2.4]heptane-6-carboxylic acid; (2S,3S)-di-4-toluoyltartaric acid With acetic acid at 60℃; for 0.333333h;
Stage #2: With ethyl acetate at 50℃; for 1.5h; Enzymatic reaction;
Stage #3: With salicylaldehyde at 50℃; for 18h;
83%
1-Benzyl-3-methyl-4-piperidon
34737-89-8

1-Benzyl-3-methyl-4-piperidon

(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

(R)-1-benzyl-3-methylpiperidin-4-one (2S,3S)-2,3-bis((4-methylbenzoyl)oxy)succinic acid salt

(R)-1-benzyl-3-methylpiperidin-4-one (2S,3S)-2,3-bis((4-methylbenzoyl)oxy)succinic acid salt

Conditions
ConditionsYield
In acetonitrile at 40℃; for 12h; Large scale;83%
In acetonitrile at 40℃; for 12h; Large scale;83%
In acetonitrile at 40℃; for 12h; Large scale;83%
(S)-methyl 2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetate

(S)-methyl 2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetate

(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

ethyl acetate
141-78-6

ethyl acetate

(S)-methyl 2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetate (2S,3S)-2,3-bis((4-methylbenzoyl)oxy)succinate ethyl acetate

(S)-methyl 2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetate (2S,3S)-2,3-bis((4-methylbenzoyl)oxy)succinate ethyl acetate

Conditions
ConditionsYield
In toluene at 45℃; Inert atmosphere;82%
(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

(+)-(S,S)-D-O,O'-di-p-toluoyltartaric acid monosodium salt

(+)-(S,S)-D-O,O'-di-p-toluoyltartaric acid monosodium salt

Conditions
ConditionsYield
With sodium hydroxide In water for 0.166667h; Sonication;82%
(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

[2R-[2α(R*),3α]]-2-[1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine
171338-27-5

[2R-[2α(R*),3α]]-2-[1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine

BFM2-(D)-DTTA
1404074-27-6

BFM2-(D)-DTTA

Conditions
ConditionsYield
In isopropyl alcohol at 50 - 55℃; for 0.333333h; Product distribution / selectivity; Industry scale;80%
didesmethylcitalopram
62498-69-5

didesmethylcitalopram

(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

A

S-(+)-1-(3-amino-propyl)-1-(4-fluoro-phenyl)-1,3-dihydro-isobenzofuran-5-carbonitrile (-)-di-p-toluoyltartrate

S-(+)-1-(3-amino-propyl)-1-(4-fluoro-phenyl)-1,3-dihydro-isobenzofuran-5-carbonitrile (-)-di-p-toluoyltartrate

B

R-1-(3-amino-propyl)-1-(4-fluoro-phenyl)-1,3-dihydro-isobenzofuran-5-carbonitrile (-)-di-p-toluoyltartrate

R-1-(3-amino-propyl)-1-(4-fluoro-phenyl)-1,3-dihydro-isobenzofuran-5-carbonitrile (-)-di-p-toluoyltartrate

Conditions
ConditionsYield
Stage #1: didesmethylcitalopram; (2S,3S)-di-4-toluoyltartaric acid In acetonitrile at 20℃;
Stage #2: In water; acetonitrile at 0 - 60℃; Solvent;
A 80%
B n/a
(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

(R)-(+)-N,α-dimethylbenzylamine
5933-40-4

(R)-(+)-N,α-dimethylbenzylamine

(R)-N-methyl-α-methylbenzylammonium di-p-toluoyl-D-tartrate

(R)-N-methyl-α-methylbenzylammonium di-p-toluoyl-D-tartrate

Conditions
ConditionsYield
In methanol; ethyl acetate at 20℃; for 1h;80%
N-methyl-N-[(S)-1-phenylethyl]amine
19131-99-8

N-methyl-N-[(S)-1-phenylethyl]amine

(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

(S)-N-methyl-α-methylbenzylammonium di-p-toluoyl-D-tartrate

(S)-N-methyl-α-methylbenzylammonium di-p-toluoyl-D-tartrate

Conditions
ConditionsYield
In methanol; ethyl acetate at 20℃; for 1h;80%
α-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethanamine
1025064-33-8

α-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethanamine

(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

(R)-cinacalcet (-)-di-para-D-toluoyl tartrate

(R)-cinacalcet (-)-di-para-D-toluoyl tartrate

Conditions
ConditionsYield
In ethyl acetate at 25 - 65℃; for 0.75h;78%
C30H30F4N4O4*C7H6O3

C30H30F4N4O4*C7H6O3

(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

(2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]succinic acid {(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-(2-methoxy-5-(trifluormethyl)phenyl)-3,4-dihydroquinazolin-4-yl}acetic acid methyl ester
917389-30-1

(2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]succinic acid {(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-(2-methoxy-5-(trifluormethyl)phenyl)-3,4-dihydroquinazolin-4-yl}acetic acid methyl ester

Conditions
ConditionsYield
Stage #1: C30H30F4N4O4*C7H6O3 With potassium phosphate In water; toluene at 20℃; for 1h;
Stage #2: With potassium phosphate; (1S,2S,4S,5R)-1-(3,5-bis(trifluoromethyl)benzyl)-2-((R)-hydroxy(1-(3-(trifluoromethyl)benzyl)quinolin-1-ium-4-yl)methyl)-5-vinylquinuclidin-1-ium bromide In water; N,N-dimethyl-formamide; toluene at 0℃;
Stage #3: (2S,3S)-di-4-toluoyltartaric acid In ethyl acetate; toluene at 20℃; for 12h;
78%
(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

C20H18O8*C13H19NO

C20H18O8*C13H19NO

Conditions
ConditionsYield
With sodium hydroxide In water; acetone at 20℃;78%
C15H18N2O2

C15H18N2O2

(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

C20H18O8*C15H18N2O2

C20H18O8*C15H18N2O2

Conditions
ConditionsYield
In water; acetonitrile Solvent;78%
trans-N-(2-hydroxycyclohexyl)-N-cyclopropylamine
726201-98-5

trans-N-(2-hydroxycyclohexyl)-N-cyclopropylamine

(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

(R)-2-cyclopropylaminocyclohexanol di-p-toluoyl-D-tartrate
339546-21-3

(R)-2-cyclopropylaminocyclohexanol di-p-toluoyl-D-tartrate

Conditions
ConditionsYield
With hydrogenchloride In methanol; water at 20 - 70℃; for 2.5h; Resolution of racemate;77.8%
rac-7-(3-pyridinyl)-1,7-diazaspiro[4.4]nonane
646055-67-6

rac-7-(3-pyridinyl)-1,7-diazaspiro[4.4]nonane

(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

(S)-7-(3-pyridinyl)-1,7-diazaspiro[4.4]nonane mono-(+)-di-O,O'-p-toluoyl-D-tartrate
1174118-94-5

(S)-7-(3-pyridinyl)-1,7-diazaspiro[4.4]nonane mono-(+)-di-O,O'-p-toluoyl-D-tartrate

Conditions
ConditionsYield
In ethanol at 20 - 50℃; Purification / work up; Reflux; Resolution of racemate;76.4%
(±)-2-(pyridin-3-ylmethylidene)-1-azabicyclo[2.2.2]octan-3-one
273748-55-3

(±)-2-(pyridin-3-ylmethylidene)-1-azabicyclo[2.2.2]octan-3-one

(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

(2S)-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]octan-3-one di-p-toluoyl-D-tartrate
1111942-08-5

(2S)-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]octan-3-one di-p-toluoyl-D-tartrate

Conditions
ConditionsYield
Stage #1: (±)-2-(pyridin-3-ylmethylidene)-1-azabicyclo[2.2.2]octan-3-one With hydrogen; palladium 10% on activated carbon In methanol at 20℃; for 12h; Industry scale;
Stage #2: (2S,3S)-di-4-toluoyltartaric acid In ethanol at 15 - 30℃; for 13h; Industry scale; Heating / reflux;
76.2%
(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

(3S,4S)-2,5-dioxotetrahydrofuran-3,4-diyl bis(4-methylbenzoate)
72842-25-2

(3S,4S)-2,5-dioxotetrahydrofuran-3,4-diyl bis(4-methylbenzoate)

Conditions
ConditionsYield
With acetic anhydride at 85℃; for 2h;76%
C23H24F3N
1206633-34-2

C23H24F3N

(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

C20H18O8*(x)C23H24F3N

C20H18O8*(x)C23H24F3N

Conditions
ConditionsYield
In ethyl acetate at 25 - 65℃; for 0.75h;74.3%
(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

3-amino-5-phenyl-1,3-dihydro-2H-benzo[b]azepin-2-one

3-amino-5-phenyl-1,3-dihydro-2H-benzo[b]azepin-2-one

(S)-3-amino-5-phenyl-1,3-dihydro-2H-benzo[b]azepin-2-one

(S)-3-amino-5-phenyl-1,3-dihydro-2H-benzo[b]azepin-2-one

Conditions
ConditionsYield
Stage #1: (2S,3S)-di-4-toluoyltartaric acid; 3-amino-5-phenyl-1,3-dihydro-2H-benzo[b]azepin-2-one In 1,4-dioxane at 20℃; for 24h;
Stage #2: With sodium hydroxide In water at 20℃; for 4h;
73.2%
Stage #1: (2S,3S)-di-4-toluoyltartaric acid; 3-amino-5-phenyl-1,3-dihydro-2H-benzo[b]azepin-2-one In 1,4-dioxane at 20℃; for 24h;
Stage #2: With sodium hydroxide at 20℃; for 4h;
73.2%
(-)-(S)-N,N-dimethyl-1-phenylethylamine
17279-31-1

(-)-(S)-N,N-dimethyl-1-phenylethylamine

(2S,3S)-di-4-toluoyltartaric acid
32634-68-7

(2S,3S)-di-4-toluoyltartaric acid

(S)-N,N-dimethyl-α-methylbenzylammonium di-p-toluoyl-D-tartrate

(S)-N,N-dimethyl-α-methylbenzylammonium di-p-toluoyl-D-tartrate

Conditions
ConditionsYield
In Isopropyl acetate Reflux;73%

32634-68-7Relevant articles and documents

Diquats with Robust Chirality: Facile Resolution, Synthesis of Chiral Dyes, and Application as Selectors in Chiral Analysis

Talele, Harish R.,Koval, Du?an,Severa, Luká?,Reyes-Gutiérrez, Paul E.,Císa?ová, Ivana,Sázelová, Petra,?aman, David,Bednárová, Lucie,Ka?i?ka, Václav,Teply, Filip

supporting information, p. 7601 - 7604 (2018/06/11)

Diquats with extremely high racemization barriers with ΔG≠theor of 233 kJ mol?1 at 180 °C are described. Reported configurational robustness is due to a combination of two structural features: the rigid o-xylylene tether connecting the nitrogen atoms and the presence of two substituents in the bay region of the bipyridinium scaffold. The straightforward synthesis of diquats, plus facile resolution and derivatization make them attractive for chiral application studies. This is demonstrated by: 1) synthesis of the first non-racemic diquat dyes with pronounced chiroptical properties, and 2) capability of diquats to interact stereospecifically with chiral molecules. This suggests potential for diquat derivatives to be used as chiral selectors in separation methods.

Recovery of optically active tartaric acid resolving agents

-

Page/Page column 4, (2008/06/13)

A process for the recovery of substituted tartaric acid resolving agents from resolution mother liquors or isolated diastereomeric salts, characterized in that the diastereomeric salt of an enantiamerically enriched amine and the substituted tartaric acid derivative in an organic solvent is treated with a base, extracting said substituted tartaric acid derivative into an aqueous phase, adding an acid to the separated aqueous phase while monitoring the pH-value, precipitating mono salts of substituted tartaric acid derivatives, isolating said mono salts, and liberating the substituted tartaric acid derivative by an acidic treatment.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 32634-68-7